Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

INAB US Equity

IN8BIO, Inc.Health Care · Biological Products, (No Diagnostic Substances) · CIK 1740279 · FY ends Dec 31
$1.20
+0.06 (+5.26%)
USD · as of 2026-08-19 · marketstack
1 8-K filing · 0 13D · 1 13G
DateEventWhat happened / filerSource
2026-08-1313G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by LYTTON LAURENCE Wsec.gov ↗
2026-08-068-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-08-06

Every row is a filed document, checked against its EDGAR index.